oles of academia, rare diseases. and repurposing in the development of the most transforma- tive drugs. Health Aff (Millwood) 2015:34: 256-93. 3. Downing NS. Aminawung JA, Shah ND. Krumholz HM. Ross JS. Clinical trial evi- dence supporting FDA approval of novel therapeutic agents. 2005.2012. JAMA 2014;